¶T¨óÛ´°¿ì®ü¥~°·±d¬ì§Þ²£·~»¡©ú
½Ã¥ÍºÖ§Q³¡©e°U¥~¶T¨ó·|°õ¦æ¡u¾ã¦X°·±d¬ì§Þ±À°Êpµe-°·±d¬ì§Þ²£·~§ë¸ê¦X§@¡v¡A©ó·í¦a®É¶¡14¤é¦bÛ´°¿ì²z
½Ã¥ÍºÖ§Q³¡©e°U¥~¶T¨ó·|°õ¦æ¡u¾ã¦X°·±d¬ì§Þ±À°Êpµe-°·±d¬ì§Þ²£·~§ë¸ê¦X§@¡v¡A©ó·í¦a®É¶¡14¤é¦bÛ´°¿ì²z²£·~»¡©ú·|¡A§Æ±æ¯à¦b¥Í§Þ¡BÂåÀø¡BÂå§÷¤ÎÃÄ«~µ¥¤è±´£¤É¥x^ÂùÃä¦X§@Ãö«Y¡C
¬¡°Êp§l¤Þ^°ê·í¦a²£·~¥Nªí¡A¥]¬A^°êÅé¥~¶EÂ_¨ó·|¡]British in-vitro Diagnostics Association¡^¡B¥þ°ê»sÃĨó·|¡B^°êÂåÀøÀË´ú¾¹§÷¨ó·|¤ÎÛ´°µo®i«P¶i¸p¡]London & Partners¡^µ¥¬ÛÃö¤½¨ó·|¤Î©x¤è¥Nªí»P·|¡C¥t¥~^°ê¥Íª«¬ì§Þ¤½¥q¦pGBUK Healthcare©MAlere Internationalµ¥·~ªÌp20¾l¤H¥X®u¡C
^°ê¥þ°ê»sÃĨó·|¡]National Pharmacy Association¡^³BªøLeyla Hannbeckªí¥Ü¡A¸Ó¨ó·|¦@¦³1¸U4000¦W·|û¡A¥]¬A^°ê³Ì¤j³sÂêÃħ©Boots¡A«Ü¼Ö·N¸ò¥xÆW¦X§@¡A¦pªG¦³»Ýn¤]¥i³qª¾©ÒÄÝ·|û¬ÛÃö°T®§¡A¨Ã°w¹ï¦³¿³½ì»P¥xÆW·~ªÌ¦X§@ªº·|û¶i¤@¨B´£¨Ñ¨ó§U¡C¦oÁÙªí¥Ü¦³¾÷·|±Nu¥xÁA¸Ñ§ó¦hÂåÀø¥Í§Þ²£·~±¡ªp¡A´M¨D¦X§@¡C
^°ê°·±d·ÓÅ@·~ªÌGBUK Healthcare ¦æ¾PÁ`ºÊJeremy Wilkisonªí¥Ü¡A¸Ó¤½¥qp¹ºu¥x§ë¸êµo®i·~°È¡A¥ç§Æ±æ¯àÀò±o¥~¶T¨ó·|¨ó§U¡C
^°êÂåÀøÀË´ú¾¹§÷¨ó·|¡]The Association for Instrumentation, Control, Automation & Laboratory Technology¡AGAMBICA¡^³Bªø¬_ªL´µ¡]Tim Collins¡^ªí¥Ü¡A¸Ó¨ó·|·|ûÄÝ©Ê»PÂåÀø»ö¾¹²£«~¬ÛÃö¡A¥i»P¥xÆW¦X§@ªº¾÷·|«Ü¦h¡A¥¼¨Ó¸Ó¨ó·|¿ì²z¬¡°Ê±NÁܽХ~¶T¨ó·|¬£û¡A¤¶²Ð¥xÆWÂåÀø¥Í§Þ¤Î¬ÛÃö¾¹§÷³]³Æµ¥²£·~µo®i²{ªp¡C
¹ê»Ú¿ì²z¸Ó¬¡°ÊªºÛ´°¥xÆW¶T©ö¤¤¤ß¥D¥ô¬x»Ê´Üªí¥Ü¡A¥»¦¸·|ij»P^°ê¬ÛÃö¥Íª«¬ì§ÞÂåÀø²£·~²`¤J·¾³q¥æ´«·N¨£¡AÅý¹ï¤è§ó¥[ÁA¸Ñ¥xÆW¡A§Æ±æ¥¼¨Ó¦³¾÷·|§l¤Þ^°ê¬ÛÃö·~ªÌ¨ì¥xÆW§ë¸ê¡C
¡i¤¤¥¡ªÀ¡j
§@ªÌ¤¶²Ð